Navigation Links
VIVUS to Participate in Three Investor Conferences in September
Date:8/31/2011

MOUNTAIN VIEW, Calif., Aug. 31, 2011 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that VIVUS management, including Leland Wilson, Chief Executive Officer; Timothy Morris, Chief Financial Officer, and Wesley W. Day, Ph.D., Vice President, Clinical Development, will participate in three investment conferences during the month of September.  

The conference presentation schedule is as follows:

Stifel Nicolaus 2011 Healthcare Conference
Wednesday, September 7, 2011
8:00 a.m. ET
Four Seasons Hotel Boston
Boston, MA

UBS Global Life Sciences Conference
Tuesday, September 20, 2011
2:00 p.m. ET
Grand Hyatt New York
New York, NY

Sixth Annual JMP Securities Healthcare Conference
Wednesday, September 28, 2011
12:00 p.m. ET
St. Regis New York
New York, NY

A live audio webcast and an archive of the presentations will be available at http://ir.vivus.com.

About VIVUS VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company's lead investigational product in clinical development, QNEXA®, has completed phase 3 clinical trials for the treatment of obesity and is currently being considered for approval by US and EU regulators. VIVUS received a Complete Response Letter, or CRL, to the initial QNEXA NDA on October 28, 2010. QNEXA is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea. In the area of sexual health, VIVUS has submitted an NDA for avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction. For more information about the company, please visit www.vivus.com.CONTACT:   VIVUS, Inc.Investor Relations:The Trout GroupTimothy E. MorrisBrian KorbChief Financial Offi
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. VIVUS Reports First Quarter 2009 Financial Results and Highlights
2. Data on VIVUS Qnexa To Be Presented During Two Podium Presentations at ADA Annual Meeting
3. VIVUS to Present at the Needham and Company Life Sciences Conference
4. VIVUS to Present at the Canaccord Adams 29th Annual Global Growth Conference
5. VIVUS to Present at Four Upcoming Healthcare Conferences
6. VIVUS Announces Positive Results From Two Phase 3 Studies; Obese Patients on Qnexa Achieve Average Weight Loss up to 14.7% and Significant Improvements in Co-Morbidities
7. VIVUS Reports Third Quarter 2009 Highlights and Financial Results
8. VIVUS to Present at Two Upcoming Investor Conferences
9. VIVUS to Present at Four Upcoming Investor Conferences
10. Data on VIVUS QNEXA to be Presented in Six Posters at The Obesity Societys Annual Meeting
11. VIVUS to Present at the 10th Annual Needham Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015 InferMed ... technology will ... evidence-based clinical s olutions suite   ... and medical information products and services, announced today the acquisition ... decision support (CDS) technology company. InferMed,s Arezzo technology ...
(Date:6/30/2015)... 2015 R-Japan Co.,Ltd. obtained the license of cell ... Medicine from the Ministry of Health, Labour and Welfare Kinki ... The fact that R- Japan ... from Pharmaceuticals and Medical Devices Agency (PMDA) on May 18, ... provide stem cell manufacturing service to medical institutions. As of ...
(Date:6/30/2015)... astronaut Kjell Lindgren , who is making final preparations ... the International Space Station , will be available for ... July 7. Lindgren will participate from the Gagarin ... . The interviews will be preceded at 7:30 a.m. by ... To schedule an interview, media must contact Stephanie ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... filter that does not sacrifice selectivity to achieve faster flow rates in comparison ... fine pores with significant open space to allow easy liquid flow while trapping ...
Breaking Biology Technology:Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4R-Japan Obtained Autologous Stem Cell Manufacturing License from the Ministry of Health, Labour and Welfare 2NASA Astronaut Preps for First Space Station Mission, Available for Media Interviews 2New Nanofiber Membrane Provides Fast, Efficient Filtration 2
... Jan. 31, 2011 PAREXEL International Corporation (Nasdaq: ... the second quarter ended December 31, 2010. ... consolidated service revenue increased by 6.9% to $304.4 million, ...  Excluding the negative impact from foreign exchange movements of ...
... N.Y., Jan. 31, 2011 Netsmart Technologies, Inc., a ... human services organizations, today announced that Paul Black has ... additional healthcare and software technology expertise to the board ... industry-leading solutions. Black served with publicly-traded ...
... Jan. 31, 2011 Haemonetics Corporation (NYSE: HAE ) ... income of $19.7 million, up 8%, and earnings per share of ... quarter net income was $ 22.6 million, up 21%, and adjusted ... was up 6%, adjusted net income was up 21%, and adjusted ...
Cached Biology Technology:PAREXEL Reports Second Quarter Fiscal Year 2011 Financial Results 2PAREXEL Reports Second Quarter Fiscal Year 2011 Financial Results 3PAREXEL Reports Second Quarter Fiscal Year 2011 Financial Results 4PAREXEL Reports Second Quarter Fiscal Year 2011 Financial Results 5PAREXEL Reports Second Quarter Fiscal Year 2011 Financial Results 6PAREXEL Reports Second Quarter Fiscal Year 2011 Financial Results 7PAREXEL Reports Second Quarter Fiscal Year 2011 Financial Results 8PAREXEL Reports Second Quarter Fiscal Year 2011 Financial Results 9PAREXEL Reports Second Quarter Fiscal Year 2011 Financial Results 10PAREXEL Reports Second Quarter Fiscal Year 2011 Financial Results 11Former Cerner Chief Operating Officer Joins Netsmart Technologies Board of Directors 2Former Cerner Chief Operating Officer Joins Netsmart Technologies Board of Directors 3Haemonetics Reports Third Quarter of Fiscal 11 2Haemonetics Reports Third Quarter of Fiscal 11 3Haemonetics Reports Third Quarter of Fiscal 11 4Haemonetics Reports Third Quarter of Fiscal 11 5Haemonetics Reports Third Quarter of Fiscal 11 6Haemonetics Reports Third Quarter of Fiscal 11 7Haemonetics Reports Third Quarter of Fiscal 11 8Haemonetics Reports Third Quarter of Fiscal 11 9Haemonetics Reports Third Quarter of Fiscal 11 10Haemonetics Reports Third Quarter of Fiscal 11 11Haemonetics Reports Third Quarter of Fiscal 11 12Haemonetics Reports Third Quarter of Fiscal 11 13
(Date:6/23/2015)... BEACH GARDENS, Fla. , June 23, ... multi-factor identity management and authentication solutions, today announced ... Altus strong, multi-factor authentication solution.  The enhancements ... of use of the DigitalPersona Altus platform ... biometric reader compatibility. In today,s ...
(Date:6/17/2015)... GERMANTOWN, Maryland , June 17, 2015 /PRNewswire/ ...   Produktlinie mit DNA-Tests verbessert den Analyseprozess und senkt ... ; Frankfurt Prime Standard: QIA) hat heute in den ... Investigator ® für die ... neuen Kits zur Erstellung genetischer Fingerabdrücke bieten eine integrierte ...
(Date:6/17/2015)... June 17, 2015  Crossmatch™, a leading provider ... its U.are.U ® 4500 fingerprint readers have ... Eateries, Inc., a San Jose, CA ... increase security, improve accountability and reduce fraud at ... non-repudiable identity confirmation for employee sign in and ...
Breaking Biology News(10 mins):Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3
... Americans with high blood pressure, more help is on the ... October 2010 print issue of The FASEB Journal ... arachidonic acid in our blood vessel walls to create a ... turns off genes responsible for vascular inflammation and ultimately relaxes ...
... USDA,s National Institute of Food and Agriculture awarded nearly ... assistance programs. "The United States is a major ... the world who are suffering during emergency situations," said ... and Agriculture (NIFA). "These projects will improve the nutritional ...
... largest renewable water resource for humans and a crucible of ... to a new global analysis. The report, published today ... first to simultaneously account for the effects of such things ... and the introduction of exotic species on the health of ...
Cached Biology News:Scientists discover a new way our bodies control blood pressure: the P450-EET system 2Report casts world's rivers in 'crisis state' 2Report casts world's rivers in 'crisis state' 3Report casts world's rivers in 'crisis state' 4
... Synthetic peptide derived from the N-terminal ... dog and orangutang occludin proteins. ... protein. Reactivity: Human (positive controls: ... rat mouse dog and orangutang is ...
...
Anti-ZFP-38/RU49 Family: Zinc Finger Peptide Sequence: SVKVEDKDFPSTCSKK...
TRIzol Reagents are ready-to-use monophasic solutions of phenol and guanidine isothiocyanate suitable for isolating total RNA DNA and proteins (16)....
Biology Products: